DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 37 filers reported holding DEXCOM INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $126,544,364 | +59.2% | 40,552,000 | +44.6% | 0.33% | +40.3% |
| Q1 2023 | $79,466,491 | +42.0% | 28,052,000 | +13719.4% | 0.24% | +62.8% |
| Q4 2022 | $55,958,000 | +46.7% | 202,990 | -98.9% | 0.14% | +19.8% |
| Q3 2022 | $38,138,000 | +55.8% | 19,257,000 | +45.3% | 0.12% | +108.6% |
| Q2 2022 | $24,471,000 | -44.3% | 13,257,000 | -6.1% | 0.06% | -22.7% |
| Q1 2022 | $43,968,000 | – | 14,125,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |